CLVS

Clovis Oncology News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Clovis Oncology Inc CLVS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 0.67% 5.98 00:00:02
Open Price Low Price High Price Close Price Prev Close
6.00 5.82 6.18 5.99 5.94
more quote information »

Recent News

Date Time Source Heading
2/25/202108:56EDGARSecurities Registration Statement (simplified Form) (s-3)
2/23/202109:11SEEKClovis Oncology shares fall after Q4 results
2/23/202108:06EDGARCurrent Report Filing (8-k)
2/23/202108:02SEEKClovis Oncology EPS misses by $0.26, beats on revenue
2/23/202108:00BWClovis Oncology Announces 2020 Operating Results
2/19/202116:18EDGARStatement of Changes in Beneficial Ownership (4)
2/17/202108:00BWClovis Oncology to Announce Fourth Quarter and Year-End 2020..
2/16/202116:37EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202114:57EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202113:46EDGARSchedule 13g
2/11/202114:39EDGARStatement of Ownership (sc 13g)
2/11/202108:00BWClovis Oncology Presents Data in Advanced Prostate Cancer at..
2/10/202110:49EDGARAmended Statement of Ownership (sc 13g/a)
2/05/202107:53EDGARStatement of Ownership (sc 13g)
2/04/202108:00BWClovis Oncology to Highlight Data at ASCO 2021 Genitourinary..
2/03/202116:17EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202116:16EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202116:16EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202116:16EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202116:16EDGARStatement of Changes in Beneficial Ownership (4)
1/11/202110:02EDGARAmended Statement of Ownership (sc 13g/a)
1/11/202108:07EDGARCurrent Report Filing (8-k)
1/11/202108:00BWClovis Oncology Announces Preliminary Product Revenues for..
12/29/202008:00BWClovis Oncology Submits Investigational New Drug..
12/23/202016:53EDGARStatement of Changes in Beneficial Ownership (4)
12/23/202016:52EDGARStatement of Changes in Beneficial Ownership (4)
12/21/202008:06EDGARCurrent Report Filing (8-k)
12/21/202008:00BWClovis Oncology’s Rubraca® (rucaparib) Met the Primary..
12/17/202006:03EDGARNotice of Effectiveness (effect)
12/16/202016:16EDGARStatement of Changes in Beneficial Ownership (4)
12/14/202016:21EDGARStatement of Changes in Beneficial Ownership (4)
12/04/202006:08EDGARSecurities Registration Statement (simplified Form) (s-3)
11/27/202016:19EDGARCurrent Report Filing (8-k)
11/24/202018:06BWClovis Oncology Announces Exercise by Existing Holder of..
11/20/202008:00BWClovis Oncology to Present at the Piper Sandler 32nd Annual..
11/17/202016:07EDGARCurrent Report Filing (8-k)
11/05/202016:47EDGARQuarterly Report (10-q)
11/05/202016:19EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202016:19EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202016:19EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202016:19EDGARStatement of Changes in Beneficial Ownership (4)
11/05/202008:05BWClovis Oncology Announces Third Quarter 2020 Operating..
11/05/202008:02BWClovis Oncology Announces Debt Exchange Transaction and..
10/20/202016:05BWClovis Oncology to Announce Third Quarter 2020 Financial..
9/23/202016:36EDGARStatement of Changes in Beneficial Ownership (4)
9/23/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
9/17/202003:05BWNew Data Presented at ESMO Virtual Congress 2020 Highlight..
9/10/202008:05BWClovis Oncology Announces Oral Plenary Session Presentation..
9/09/202008:05BWClovis Oncology to Highlight Data for its Three Portfolio..
9/08/202016:22EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
NASDAQ
CLVS
Clovis Onc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.